IKT Competitors & Alternatives
Compare Inhibikase Therapeutics Inc with similar stocks in the same industry
Biotechnology
IKT
Main Stock$1.61
Tradestie Score
46
Market Cap
$119.97M
Revenue Growth
-1.0%
Analyst Upside
+272.7%
Top Competitors
230 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
OMER
Omeros Corporation
|
$11.70
|
$281.75M | 10.7 | 55 | Compare |
|
DBVT
DBV Technologies S.A.
|
$18.75
|
$275.54M | - | 52 | Compare |
|
ALLO
Allogene Therapeutics, Inc. Common Stock
|
$1.94
|
$275.13M | - | 48 | Compare |
|
VOR
Vor Biopharma Inc. Common Stock
|
$14.13
|
$269.08M | - | 50 | Compare |
|
KYTX
Kyverna Therapeutics, Inc. Common Stock
|
$8.54
|
$258.18M | - | 54 | Compare |
|
VTYX
Ventyx Biosciences, Inc. Common Stock
|
$14.00
|
$256.71M | - | 53 | Compare |
|
CABA
Cabaletta Bio, Inc. Common Stock
|
$3.29
|
$211.28M | - | 54 | Compare |
|
SLS
SELLAS Life Sciences Group, Inc. Common Stock
|
$7.29
|
$211.22M | - | 63 | Compare |
|
ACRS
Aclaris Therapeutics, Inc.
|
$4.40
|
$202.58M | - | 52 | Compare |
|
CBIO
Crescent Biopharma, Inc. Common Stock
|
$18.55
|
$199.71M | - | 51 | Compare |
More IKT Analysis
Data updated: May 18, 2026 | Industry: Biotechnology (SIC 2836)
230 stocks in this industry